Clinical evaluation of Affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis

Haywood L. Brown, Deanna D. Fuller, Lori T. Jasper, Thomas Davis, Justin D. Wright

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Objective: To compare the Affirm VPIII Microbial Identification Test for detection and identification of Candida species, Gardnerella vaginalis and Trichomonas vaginalis to clinical and microscopic criteria commonly used to diagnose vaginitis. Methods: Women that were symptomatic for vaginitis/vaginosis and asymptomatic women being seen for routine obstetric or gynecological care were included in this study. Women treated with antibiotics or antifungals within one week or women who had douched within 24 hours were excluded. Two vaginal swab specimens were simultaneously obtained from each patient, one swab was placed in sterile physiological saline for immediate microscopic wet mount examination and KOH testing. The other swab was placed in the Affirm collection tube for Affirm VPIII testing based on previously demonstrated methods. Results: The Affirm assay was significantly more likely to identify Gardnerella and Candida than wet mount. 190 (45%) were positive for Gardnerella by Affirm compared to 58 (14%) by wet mount; 45 (11%) were positive for Candida by Affirm compared to 31 (7%) by wet mount; and 30 (7%) were positive for Trichomonas by Affirm compared to 23 (5%) by wet mount. Symptomatic women were significantly more likely to be positive by Affirm only (23% vs. 10%), wet mount only (3% vs. 2%) or Affirm and wet mount (15% vs. 1%). Asymptomatic women were significantly more likely to be negative for Affirm and wet mount (43% vs. 5%). Conclusions: The Affirm VPIII test is a more sensitive diagnostic test for detection and identification of symptomatic vaginitis/vaginosis than conventional clinical examination and wet mount testing.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalInfectious Diseases in Obstetrics and Gynecology
Volume12
Issue number1
DOIs
StatePublished - 2004

Fingerprint

Gardnerella vaginalis
Vaginitis
Trichomonas vaginalis
Candida
Gardnerella
Trichomonas
Antifungal Agents
Routine Diagnostic Tests
Obstetrics

Keywords

  • Affirm
  • Evaluation
  • Vaginitis

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Dermatology

Cite this

Clinical evaluation of Affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. / Brown, Haywood L.; Fuller, Deanna D.; Jasper, Lori T.; Davis, Thomas; Wright, Justin D.

In: Infectious Diseases in Obstetrics and Gynecology, Vol. 12, No. 1, 2004, p. 17-21.

Research output: Contribution to journalArticle

@article{93775482537147c5b81449fa4c39a142,
title = "Clinical evaluation of Affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis",
abstract = "Objective: To compare the Affirm VPIII Microbial Identification Test for detection and identification of Candida species, Gardnerella vaginalis and Trichomonas vaginalis to clinical and microscopic criteria commonly used to diagnose vaginitis. Methods: Women that were symptomatic for vaginitis/vaginosis and asymptomatic women being seen for routine obstetric or gynecological care were included in this study. Women treated with antibiotics or antifungals within one week or women who had douched within 24 hours were excluded. Two vaginal swab specimens were simultaneously obtained from each patient, one swab was placed in sterile physiological saline for immediate microscopic wet mount examination and KOH testing. The other swab was placed in the Affirm collection tube for Affirm VPIII testing based on previously demonstrated methods. Results: The Affirm assay was significantly more likely to identify Gardnerella and Candida than wet mount. 190 (45{\%}) were positive for Gardnerella by Affirm compared to 58 (14{\%}) by wet mount; 45 (11{\%}) were positive for Candida by Affirm compared to 31 (7{\%}) by wet mount; and 30 (7{\%}) were positive for Trichomonas by Affirm compared to 23 (5{\%}) by wet mount. Symptomatic women were significantly more likely to be positive by Affirm only (23{\%} vs. 10{\%}), wet mount only (3{\%} vs. 2{\%}) or Affirm and wet mount (15{\%} vs. 1{\%}). Asymptomatic women were significantly more likely to be negative for Affirm and wet mount (43{\%} vs. 5{\%}). Conclusions: The Affirm VPIII test is a more sensitive diagnostic test for detection and identification of symptomatic vaginitis/vaginosis than conventional clinical examination and wet mount testing.",
keywords = "Affirm, Evaluation, Vaginitis",
author = "Brown, {Haywood L.} and Fuller, {Deanna D.} and Jasper, {Lori T.} and Thomas Davis and Wright, {Justin D.}",
year = "2004",
doi = "10.1080/1064744042000210375",
language = "English",
volume = "12",
pages = "17--21",
journal = "Infectious Diseases in Obstetrics and Gynecology",
issn = "1064-7449",
publisher = "Hindawi Publishing Corporation",
number = "1",

}

TY - JOUR

T1 - Clinical evaluation of Affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis

AU - Brown, Haywood L.

AU - Fuller, Deanna D.

AU - Jasper, Lori T.

AU - Davis, Thomas

AU - Wright, Justin D.

PY - 2004

Y1 - 2004

N2 - Objective: To compare the Affirm VPIII Microbial Identification Test for detection and identification of Candida species, Gardnerella vaginalis and Trichomonas vaginalis to clinical and microscopic criteria commonly used to diagnose vaginitis. Methods: Women that were symptomatic for vaginitis/vaginosis and asymptomatic women being seen for routine obstetric or gynecological care were included in this study. Women treated with antibiotics or antifungals within one week or women who had douched within 24 hours were excluded. Two vaginal swab specimens were simultaneously obtained from each patient, one swab was placed in sterile physiological saline for immediate microscopic wet mount examination and KOH testing. The other swab was placed in the Affirm collection tube for Affirm VPIII testing based on previously demonstrated methods. Results: The Affirm assay was significantly more likely to identify Gardnerella and Candida than wet mount. 190 (45%) were positive for Gardnerella by Affirm compared to 58 (14%) by wet mount; 45 (11%) were positive for Candida by Affirm compared to 31 (7%) by wet mount; and 30 (7%) were positive for Trichomonas by Affirm compared to 23 (5%) by wet mount. Symptomatic women were significantly more likely to be positive by Affirm only (23% vs. 10%), wet mount only (3% vs. 2%) or Affirm and wet mount (15% vs. 1%). Asymptomatic women were significantly more likely to be negative for Affirm and wet mount (43% vs. 5%). Conclusions: The Affirm VPIII test is a more sensitive diagnostic test for detection and identification of symptomatic vaginitis/vaginosis than conventional clinical examination and wet mount testing.

AB - Objective: To compare the Affirm VPIII Microbial Identification Test for detection and identification of Candida species, Gardnerella vaginalis and Trichomonas vaginalis to clinical and microscopic criteria commonly used to diagnose vaginitis. Methods: Women that were symptomatic for vaginitis/vaginosis and asymptomatic women being seen for routine obstetric or gynecological care were included in this study. Women treated with antibiotics or antifungals within one week or women who had douched within 24 hours were excluded. Two vaginal swab specimens were simultaneously obtained from each patient, one swab was placed in sterile physiological saline for immediate microscopic wet mount examination and KOH testing. The other swab was placed in the Affirm collection tube for Affirm VPIII testing based on previously demonstrated methods. Results: The Affirm assay was significantly more likely to identify Gardnerella and Candida than wet mount. 190 (45%) were positive for Gardnerella by Affirm compared to 58 (14%) by wet mount; 45 (11%) were positive for Candida by Affirm compared to 31 (7%) by wet mount; and 30 (7%) were positive for Trichomonas by Affirm compared to 23 (5%) by wet mount. Symptomatic women were significantly more likely to be positive by Affirm only (23% vs. 10%), wet mount only (3% vs. 2%) or Affirm and wet mount (15% vs. 1%). Asymptomatic women were significantly more likely to be negative for Affirm and wet mount (43% vs. 5%). Conclusions: The Affirm VPIII test is a more sensitive diagnostic test for detection and identification of symptomatic vaginitis/vaginosis than conventional clinical examination and wet mount testing.

KW - Affirm

KW - Evaluation

KW - Vaginitis

UR - http://www.scopus.com/inward/record.url?scp=3142676781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142676781&partnerID=8YFLogxK

U2 - 10.1080/1064744042000210375

DO - 10.1080/1064744042000210375

M3 - Article

C2 - 15460191

AN - SCOPUS:3142676781

VL - 12

SP - 17

EP - 21

JO - Infectious Diseases in Obstetrics and Gynecology

JF - Infectious Diseases in Obstetrics and Gynecology

SN - 1064-7449

IS - 1

ER -